Azithromycin is used in the treatment of bacterial infection caused by susceptible bacteria: Lower respiratory tract infections: bronchitis, pneumonia.
Upper respiratory tract infections: sinusitis, pharyngitis/tonsillitis (Penicillin is the usual drug of choice in the treatment of Streptococcus pyogenes pharyngitis including the prophylaxis of rheumatic fever. Azithromycin is generally effective in the eradication of streptococci from the oropharynx, however, data establishing the efficacy of Azithromycin and the subsequent prevention of rheumatic fever are not available at present.).
Odontostomatological infections.
Acute otitis media.
Skin and soft tissue infections.
Sexually transmitted diseases: uncomplicated genital infections due to Chlamydia trachomatis, chancroid due to Haemophilus ducreyi, uncomplicated genital infections due to non-multiresistant Neisseria gonorrhoeae, concurrent infection with Treponema pallidum should be excluded. Moreover, Azithromycin is indicated, either alone or in combination with rifabutin, for prophylaxis against Mycobacterium avium-intracellulare complex (MAC), an opportunistic infection prevalent in patients with advanced human immunodeficiency virus (HIV).
Azithromycin is indicated in combination with ethambutol for the treatment of disseminated MAC (DMAC) infection in patients with advanced HIV infection.
Azithromycin intravenous is indicated for the treatment of community acquired pneumonia (CAP) caused by susceptible organisms, including Legionella pneumophila, in patients who require initial intravenous therapy.
Azithromycin intravenous is indicated for the treatment of pelvic inflammatory diseases (PID) caused by susceptible organisms (Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma hominis), in patients who require initial intravenous therapy.
Sign Out